KIR3DL1 and Cirrhosis: Of clinical relevance, decreased expression of KIR3DL1 in the presence of its ligand was observed in peripheral blood CD56dim NK cells from patients who did not progress to cirrhosis in the group of early-infected CHCV patients, suggesting that lower expression of KIR3DL1 may delay progression to cirrhosis.